These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 497518)

  • 1. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
    Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
    J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
    Yamaguchi I; Singh BN; Mandel WJ
    Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
    Burke GH; Loukides JE; Berman ND
    J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tetracyclic antidepressant drugs on the electrophysiological properties of canine cardiac Purkinje fibres.
    Brennan FJ; Cassidy DM
    Can J Cardiol; 1988 Sep; 4(6):281-6. PubMed ID: 3179792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance.
    Imanishi S; Arita M; Kiyosue T; Aomine M
    J Pharmacol Exp Ther; 1983 Apr; 225(1):198-205. PubMed ID: 6300374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the potassium channel activator, BRL 34915, on the action potential characteristics of canine cardiac Purkinje fibers.
    Bril A; Man RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1090-6. PubMed ID: 2359018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of therapeutic concentrations of diphenylhydantoin on transmembrane potentials of normal and depressed Purkinje fibers.
    Rosen MR; Danilo P; Alonso MB; Pippenger CE
    J Pharmacol Exp Ther; 1976 Jun; 197(3):594-604. PubMed ID: 932992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local anesthetic and negative chronotropic effects of diltiazem on canine cardiac Purkinje fibers.
    Dangman KH; Ziam S; Miura DS
    Am Heart J; 1989 Jun; 117(6):1271-7. PubMed ID: 2729055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lidocaine and on slow response and depressed fast response action potentials of canine cardiac Purkinje fibers.
    Brennan FJ; Cranefield PF; Wit AL
    J Pharmacol Exp Ther; 1978 Feb; 204(2):312-24. PubMed ID: 621666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dantrolene sodium on the electrophysiological properties of canine cardiac Purkinje fibers.
    Salata JJ; Jalife J
    J Pharmacol Exp Ther; 1982 Jan; 220(1):157-66. PubMed ID: 7053411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of GYKI-23 107, a new antiarrhythmic compound, in isolated rabbit and canine cardiac preparations.
    Varró A; Németh M; Rabloczky G; Papp JG; Szekeres L
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):251-7. PubMed ID: 2452917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential electrophysiologic effects of mexiletine on normal and hypoxic canine Purkinje fibers.
    Burke GH; Berman ND
    J Cardiovasc Pharmacol; 1985; 7(6):1096-100. PubMed ID: 2418294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.
    Kus T; Sasyniuk BI
    Circ Res; 1975 Dec; 37(6):844-54. PubMed ID: 1192576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.